The EBNA-1 (Epstein-Barr nuclear antigen 1) test is a diagnostic tool used to detect the presence of EBNA-1 antibodies in the blood. EBNA-1 is a protein produced by the Epstein-Barr virus (EBV) during its latency phase inside infected cells. This test helps in confirming an EBV infection and distinguishing it from other conditions with similar symptoms. It is particularly useful in diagnosing mononucleosis and assessing the risk of developing EBV-associated cancers, such as Hodgkin's lymphoma and nasopharyngeal carcinoma. The EBNA-1 test offers a reliable and quick method to aid healthcare professionals in determining the presence and progression of an EBV infection in patients.
To continue booking, you need to select at least 1 test
* Results are available same day by 9 p.m. 99% of the time. On rare occasions, it may take up to 3 business days to receive results.
These tests are employed for the following purposes:
To aid in the diagnosis of infectious mononucleosis (mono).
To differentiate between an Epstein-Barr virus (EBV) infection and another ailment presenting similar symptoms.
To assess an individual's susceptibility to EBV.
These tests may be requested in the following situations:
There is no preparation needed.
Epstein-Barr virus (EBV) is generally responsible for causing mild to moderate illness. Blood tests for EBV identify antibodies to the virus within the bloodstream, aiding in the diagnosis of an EBV infection. The virus is very contagious and easily passed from person to person. It is present in the saliva of infected individuals and can be spread through close contact such as kissing and through sharing utensils or cups.
EBV infection typically occurs during childhood and often presents with minimal or no symptoms. Nonetheless, when the initial infection takes place during adolescence, it can lead to infectious mononucleosis, commonly referred to as mono. Mono is characterized by symptoms like fatigue, fever, sore throat, swollen lymph nodes, an enlarged spleen, and occasionally an enlarged liver. These symptoms manifest in approximately 25% of infected teenagers and young adults and typically subside within a month or two.
EBV antibody tests are used to ascertain whether the symptoms being experienced by individuals are a result of a current EBV virus infection or not. Testing serves the purpose of distinguishing a primary EBV infection, which has not been demonstrated to impact a developing fetus, from infections such as CMV, herpes simplex virus, or toxoplasmosis. These particular illnesses can potentially lead to pregnancy complications and pose risks to the unborn baby.
Throughout a primary EBV infection, the levels of these EBV antibodies undergo fluctuations at different stages of the infection. Analyzing these antibodies in the blood can assist in diagnosis and generally offers the healthcare provider insights into the infection's stage, indicating whether it is a current, recent, or past infection.
The Centers for Disease Control and Prevention (CDC) recommend ordering several tests to help determine whether a person is susceptible to EBV or to detect a recent infection or a prior infection, or a reactivated EBV infection. These tests include:
EBNA typically doesn't appear until the acute infection has cleared, usually emerging approximately 2 to 4 months after the initial infection and persisting for a person's lifetime.
Reactivation of the virus is generally not a health concern unless the individual experiences substantial and persistent immunocompromise, which can occur in individuals with conditions like HIV/AIDS or in organ transplant recipients. In such cases, primary infections can be more severe, and some individuals may encounter chronic EBV-related symptoms.
Best Prices
Our fully automated private laboratory with cutting edge technology is able to reduce costs while increasing consistency and reproducibility of results.
Faster Service
We have designed our clinics and testing processes to be efficient, reducing wait times and time for results.
More Precise Information
Our test reports provide more precise information on test results, making it easier to monitor any changes in your health over time.
Free Parking
All our clinics provide free and available parking, helping you to save even more money and time.
Customer Support
Our online booking portal and helpful testing center staff help to make diagnostic testing more convenient and compassionate.
IMPLEMENT AFFORDABLE ACTION
Companies and institutions can deploy large-scale diagnostic testing at a fraction of the cost of testing centers with Lilium’s automated laboratory testing platforms and reporting.
STAY AHEAD OF OUTBREAKS
Lilium's pioneering testing system secures workplaces and communities against expensive shutdowns by keeping businesses and organizations ahead of outbreaks.
REDUCE RISKS
Robotic analysis improves accuracy of results by drastically reducing the risk of false negatives and positives.
To make an appointment, please choose from one of our clinics below:
Monday - Saturday
7:00 - 10:00
12:00 - 15:00
We provide FREE parking at our convenient locations
Our downtown Montreal location is located on the mezzanine level of the Alexis Nihon Center with 1 hour free indoor parking. Atwater metro station has a direct inside connection to Alexis Nihon.
If you’re driving to our Laval location, we are right off Autoroute 15 and have plenty of free parking.
If you arrive by public metro, there is a walkway to our lab from Metro Montmorency (a 20 minute walk).
What our customers say about us
ASK US ANYTHING
We're here to help make sense of it all.
Or send us an e-mail